LUNGevity Foundation
As a young researcher just completing his MD and PhD at Johns Hopkins University in 1988, Dr. David Carbone was looking for ways to apply the latest tools in molecular biology. He wanted to make an impact. After attending a talk about cancer mutations, Dr. Carbone realized that lung cancer was inadequately treated and lung cancer patients could really benefit from genetic and molecular therapeutics. Since then, Dr. Carbone has been striving to improve lung cancer detection and treatment.
The results of his work have been far-reaching. From discovering factors that cause cancer-associated immunosuppression to developing serum protein biomarker tests, Dr. Carbone has made a tremendous impact on lung cancer. Armed with intense scientific curiosity and dogged determination, Dr. Carbone has published more than 150 peer-reviewed publications and review articles. He is often invited to serve on NCI grant review panels and his laboratory has earned continuous NCI funding since early in his career.
This person is not in the org chart
This person is not in any offices
LUNGevity Foundation
2 followers
LUNGevity Foundation is the nation's leading lung cancer organization focused on improving outcomes for people with lung cancer through research, policy initiatives, education, support, and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live longer and better lives.